Stephanie R. Harrison
Leeds, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Prevalence, outcomes, and predictive factors: a systematic literature review to inform the development of EULAR Points to Consider for the definition of Difficult-to-Manage and Treatment-Refractory psoriatic arthritis.
Journal: EULAR rheumatology open
Published: August 01, 2026
Difficult-to-treat, complex-to-manage, treatment-refractory spondyloarthritis: semantics or substance?
Journal: Current opinion in rheumatology
Published: June 12, 2026
Two patterns of sacroiliac joint bone marrow oedema are apparent in AxSpA determined by HLA-B27 status, body mass index or psoriasis.
Journal: Joint bone spine
Published: March 28, 2026
Two Patterns of Sacroiliac Joint Bone Marrow Oedema are apparent in AxSpA Determined by HLA-B27 Status, Body Mass Index or Psoriasis.
Journal: Joint bone spine
Published: March 28, 2026
Long-term treatment transition patterns after intensive treatment strategies in early psoriatic arthritis: insights from the GOLMePsA clinical trial.
Journal: The Lancet. Rheumatology
Published: February 03, 2026
Comment on: FIB-4 as an effective screening tool in psoriatic arthritis patients at high-risk for liver disease: a cross-sectional study using FibroScan: reply.
Journal: Rheumatology (Oxford, England)
Published: January 19, 2026
Beyond the scales: time to prioritise treatment of obesity in psoriatic disease.
Journal: Annals of the rheumatic diseases
Published: November 12, 2025
FIB-4 as an effective screening tool in psoriatic arthritis patients at high-risk for liver disease: a cross-sectional study using FibroScan.
Journal: Rheumatology (Oxford, England)
Published: July 23, 2025
EULAR points to consider and consensus definitions for difficult-to-manage and treatment-refractory psoriatic arthritis.
Journal: Annals of the rheumatic diseases
Published: July 04, 2025
Similar rates of new psoriatic arthritis diagnoses in a dedicated psoriatic disease triage clinic, regardless of referral route.
Journal: Rheumatology advances in practice
Published: April 14, 2025
Executive Summary: The 2025 British Society for Rheumatology guideline for the treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs.
Journal: Rheumatology (Oxford, England)
Published: January 23, 2025
The 2025 British Society for Rheumatology guideline for the treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs.
Journal: Rheumatology (Oxford, England)
Published: August 31, 2024
Last Updated: 09/26/2026